Table 1.

Characteristics of Study Subjects (n=46)^*

Age (years)	60.6 ± 8.2 (43.1 – 77)
Gender	21 F/25 M (45.6 % Female)
Body mass index (kg/m2)	26.6 ± 6.2 (18 – 52)
Hypertension (yes/no)	15/31
Triglycerides (mg/dl)	109.11 ± 63.11 (31 – 356)
High density lipoprotein (mg/dl)	53.1 ± 15.3 (27 – 98)
Fasting Glucose (mg/dl)	81.1 ± 10.7 (59 – 111)
Fasting insulin (μU/ml)	7.7±4.50 (1.00 –19.00)
HOMA	1.6 ± 1.0 (0.14 – 3.99)
C-reactive protein (mg/dl)	2.3 ± 2.3 (0.2 – 9.3)
AVR	0.69 ± 0.07 (0.56 – 0.9)
CRAE (μm)	178.31 ± 20.89 (139.86 – 219.87)
CRVE (μm)	259.87 ± 31.82 (206.40 – 327.52)
Global Atrophy (cc)	103.93 ± 42.92 (47.01 – 207.0)

^*Values are given as mean ± standard deviation (range)

HOMA= homeostasis model assessment index

AVR=arteriolar-to-venular-ratio

CRAE= central retinal arteriolar equivalent

CRVE= central retinal venular equivalent